The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision

The high rate of tick-borne encephalitis (TBE) morbidity is lasting for recent years in many areas of Russian Federation. Vac- cination with TBE vaccine is considered to be most effective mean of TBE prophylaxis in endemic areas. VIRION branch (in Tomsk) of MICROGEN State Company have been producing...

Full description

Saved in:
Bibliographic Details
Main Authors: M. S. Vorob’Eva, M. N. Rashchepkina, L. I. Pavlova, L. D. Bystritsky, N. H. Stavitskaya, T. E. Iltchenko, G. P. Bilalova, I. A. Mishchenko, O. I. Sharova
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2006-12-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/3198
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399008733167616
author M. S. Vorob’Eva
M. N. Rashchepkina
L. I. Pavlova
L. D. Bystritsky
N. H. Stavitskaya
T. E. Iltchenko
G. P. Bilalova
I. A. Mishchenko
O. I. Sharova
author_facet M. S. Vorob’Eva
M. N. Rashchepkina
L. I. Pavlova
L. D. Bystritsky
N. H. Stavitskaya
T. E. Iltchenko
G. P. Bilalova
I. A. Mishchenko
O. I. Sharova
author_sort M. S. Vorob’Eva
collection DOAJ
description The high rate of tick-borne encephalitis (TBE) morbidity is lasting for recent years in many areas of Russian Federation. Vac- cination with TBE vaccine is considered to be most effective mean of TBE prophylaxis in endemic areas. VIRION branch (in Tomsk) of MICROGEN State Company have been producing inactivated TBE vaccines for more than 40 years. Since 2001 VIRION have been producing and selling novel purified concentrated TBE vaccine EnceVir. Vaccine EnceVir contains inactivated TBE virus of Far Eastern subtype as active substance with high level of its purity. The vaccine substantiated high level of immuno- genicy and safety in adult and children clinical trials. Postmarketing surveillance during 2001—2005 has verified these conclusions. Hence EnceVir is effective, safe and most available regarding value vaccine for mass vaccination campaign in Russian Federation.
format Article
id doaj-art-ccaf0a57bc0343eca9a5ec7904b9676f
institution Kabale University
issn 1682-0363
1819-3684
language English
publishDate 2006-12-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj-art-ccaf0a57bc0343eca9a5ec7904b9676f2025-08-20T03:38:26ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842006-12-0150637110.20538/1682-0363-2006--63-711854The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provisionM. S. Vorob’Eva0M. N. Rashchepkina1L. I. Pavlova2L. D. Bystritsky3N. H. Stavitskaya4T. E. Iltchenko5G. P. Bilalova6I. A. Mishchenko7O. I. Sharova8Государственный НИИ стандартизации и контроля медицинских биологических препаратов им. Л.А. ТарасевичаГосударственный НИИ стандартизации и контроля медицинских биологических препаратов им. Л.А. ТарасевичаГосударственный НИИ стандартизации и контроля медицинских биологических препаратов им. Л.А. ТарасевичаФГУП НПО «Микроген», филиал в г. Томске НПО «Вирион»ФГУП НПО «Микроген», филиал в г. Томске НПО «Вирион»ФГУП НПО «Микроген», филиал в г. Томске НПО «Вирион»ФГУП НПО «Микроген», филиал в г. Томске НПО «Вирион»ФГУП НПО «Микроген», филиал в г. Томске НПО «Вирион»ФГУП НПО «Микроген», филиал в г. Томске НПО «Вирион»The high rate of tick-borne encephalitis (TBE) morbidity is lasting for recent years in many areas of Russian Federation. Vac- cination with TBE vaccine is considered to be most effective mean of TBE prophylaxis in endemic areas. VIRION branch (in Tomsk) of MICROGEN State Company have been producing inactivated TBE vaccines for more than 40 years. Since 2001 VIRION have been producing and selling novel purified concentrated TBE vaccine EnceVir. Vaccine EnceVir contains inactivated TBE virus of Far Eastern subtype as active substance with high level of its purity. The vaccine substantiated high level of immuno- genicy and safety in adult and children clinical trials. Postmarketing surveillance during 2001—2005 has verified these conclusions. Hence EnceVir is effective, safe and most available regarding value vaccine for mass vaccination campaign in Russian Federation.https://bulletin.ssmu.ru/jour/article/view/3198клещевой энцефалитвакцинопрофилактикавакцинаклинические испытаниярегиональные про- граммыстоимость вакцинациивакцина «энцевир»иммуногенностьбезопасностьtick-borne encephalitisvaccineclinical trialregional programtbe vaccinationvaccination costvaccine en- cevirimmunogenicysafety
spellingShingle M. S. Vorob’Eva
M. N. Rashchepkina
L. I. Pavlova
L. D. Bystritsky
N. H. Stavitskaya
T. E. Iltchenko
G. P. Bilalova
I. A. Mishchenko
O. I. Sharova
The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
Бюллетень сибирской медицины
клещевой энцефалит
вакцинопрофилактика
вакцина
клинические испытания
региональные про- граммы
стоимость вакцинации
вакцина «энцевир»
иммуногенность
безопасность
tick-borne encephalitis
vaccine
clinical trial
regional program
tbe vaccination
vaccination cost
vaccine en- cevir
immunogenicy
safety
title The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
title_full The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
title_fullStr The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
title_full_unstemmed The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
title_short The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
title_sort present vaccinoprophilaxis of tick borne encephalitis and vaccines for its provision
topic клещевой энцефалит
вакцинопрофилактика
вакцина
клинические испытания
региональные про- граммы
стоимость вакцинации
вакцина «энцевир»
иммуногенность
безопасность
tick-borne encephalitis
vaccine
clinical trial
regional program
tbe vaccination
vaccination cost
vaccine en- cevir
immunogenicy
safety
url https://bulletin.ssmu.ru/jour/article/view/3198
work_keys_str_mv AT msvorobeva thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT mnrashchepkina thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT lipavlova thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT ldbystritsky thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT nhstavitskaya thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT teiltchenko thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT gpbilalova thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT iamishchenko thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT oisharova thepresentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT msvorobeva presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT mnrashchepkina presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT lipavlova presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT ldbystritsky presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT nhstavitskaya presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT teiltchenko presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT gpbilalova presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT iamishchenko presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision
AT oisharova presentvaccinoprophilaxisoftickborneencephalitisandvaccinesforitsprovision